Phathom Pharmaceuticals, Inc. (PHAT) — Operating Income

Annual figures by fiscal year, from SEC filings.

2018: -$1.23M2019: -$106.22M2020: -$125.67M2021: -$135.08M2022: -$172.44M2023: -$167.31M2024: -$277.47M2025: -$159.99M-$159.99M
2018Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$159.99M+42.3%
2024-$277.47M-65.8%
2023-$167.31M+3.0%
2022-$172.44M-27.7%
2021-$135.08M-7.5%
2020-$125.67M-18.3%
2019-$106.22M-8570.6%
2018-$1.23M